Shares of Catalyst Pharmaceuticals jumped 4.82% to $3.81 at 14:07 EST on Monday, after two sequential sessions in a row of gains. The Nasdaq Stock Market is rising 0.83% to $12,480.50, following yesterday’s downward trend, This seems, as yet, a somewhat positive trend trading session today.

Catalyst Pharmaceuticals’s last close was $3.63, 38.76% under its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 11.6% for the ongoing quarter and 4.6% for the next. The company’s growth estimates for the present quarter is 25% and a drop 10% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Catalyst Pharmaceuticals’s Stock Top and Bottom Yearly Value

Catalyst Pharmaceuticals’s stock is valued at $3.81 at 14:07 EST, way under its 52-week high of $5.28 and way above its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is way above its 50-day moving average of $3.37 and above its 200-day moving average of $3.79.

LEAVE A REPLY

Please enter your comment!
Please enter your name here